Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma

Blood

Volumn 88, Issue 12, 1996, Pages 4667-4675

  Kanegane, Hirokazu ^a   Wang, Frederick ^b   Tosato, Giovanna ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KILLER CELL; LYMPHOBLASTOMA; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0029912734     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4667.bloodjournal88124667     Document Type: Article

References (49)

1. Liebowitz D, Kieff E: Epstein-Barr virus, in Roizman B, Whitley RJ, Lopez C (eds): The Human Herpesviruses. New York, NY, Raven, 1993, p 107
2. Miller G: Epstein-Barr virus. Biology, pathogenesis, and medical aspects, in Fields BN, Knipe DM (eds): Fields Virology (ed 2). New York, NY, Raven, 1990, p 1921
3. Straus SE, Cohen JI, Tosato G, Meier J: Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 118:45, 1993
4. Klein G: The relationship of the virus to nasopharyngeal carcinoma, in Epstein MA, Achong BG (eds): The Epstein-Barr Virus. New York, NY, Springer Verlag, 1979, p 339
5. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
6. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320, 1991
7. Weiss LM, Chen YY, Liu XF, Shibata D: Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259, 1991
8. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469, 1991
9. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131, 1994
10. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Parmley RT, Dicarlo FJ, Chadwick EG, Murphy SB: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12, 1995
11. Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19, 1995
12. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318:733, 1988
13. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128, 1990
14. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY: Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 77:799, 1991
15. Kawa-Ha K, Ishihara S, Ninomiya T, Yumara-Yagi K, Hara J, Murayama F, Tawa A, Hirai K: CDS-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51, 1989
16. Lindhout E, Lakeman A, Mevissen MLCM, de Groot C: Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines. J Exp Med 179:1173, 1994
17. Jones K, Rivera C, Sgadari C, Franklin J, Max EE, Bhatia K, Tosato G: Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 182:1213, 1995
18. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791, 1994
19. Tierney RJ, Steven N, Young LS, Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374, 1994
20. Chen F, Zou JZ, Di Renzo L, Winberg G, H L-F, Klein E, Klein G, Ernberg I: A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69:3752, 1995
21. Miyashila EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
22. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E: Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 88:6343, 1991
23. Schaefer BC, Woisetschlager M, Strominger JL, Speck SH: Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters utilized in latently infected lymphocytes. Proc Natl Acad Sci USA 88:6550, 1991
24. Hart DNJ, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, Rowe M, Beard MEJ: Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 79:2116, 1992
25. Fukunaga Y, Asano T, Takehana J, Ambo K, Matsuoka K, Yamamoto M: CD3-negative lymphoproliferative disease of granular lymphocytes in a girl with an unusual pattern of anti-Epstein-Barr virus antibodies. Eur J Pediatr 153:894, 1994
26. Kaneko T, Fukuda J, Yoshihara T, Zheng H, Mon S, Mizoguchi H, Oshimi K: Nasal natural killer (NK) cell lymphoma: Report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their pheno-type and cytotoxicity with normal NK cells. Br J Haematol 91:355, 1995
27. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M, Uchiyama T, Maeda M: TCGF (IL 2)-receptor inducing factors. I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 134:1623, 1985
28. Yoneda N, Tatsumi E, Kawano S, Teshigawara K, Oka T, Fukuda M, Yamaguchi N: Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT. Leukemia 6:136, 1992
29. Uchiyama T, Broder S, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126:1393, 1981
30. Tsudo M, Kitamura F, Miyasaka M: Characterization of the interleukin 2 receptor β chain using three distinct monoclonal antibodies. Proc Natl Acad Sci USA 86:1982, 1989
31. Ishii N, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, Sugamura K: Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int Immunol 6:1273, 1994
32. Pearson GR, Vroman B, Chase B, Sculley T, Hummel M, Kieff E: Identification of polypeptide components of the Epstein-Barr virus early antigen complex using monoclonal antibodies. J Virol 47:193, 1983
33. Kanegane H, Tosato G: Activation of naive and memory T cells by IL-15. Blood 88:230, 1996
34. Mann KP, Staunton D, Thorley-Lawson DA: Epstein-Barr virus-encoded protein found in plasma membrane of transformed cells. J Virol 55:710, 1985
35. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB: Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 68:1575, 1987
36. Young S , Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritx J, Shapiro RS, Rickinson A, Kieff E, Cohen JI: Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080, 1989
37. Kunimoto M, Tamura S, Tabata T, Yoshie O: One-step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 virus in Japan. J Gen Virol 73:455, 1992
38. Sinka SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD: Characterization of the EBV/C3d receptor on the human Jurkat T cell line: Evidence for a novel transcript. J Immunol 150:5311, 1993
39. Chen F, Hu LF, Ernberg I, Klein G, Winberg G: Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinoma. J Gen Virol 76:131, 1995
40. Gardella T, Medveczky P, Sairenji T, Mulder C: Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J Virol 50:248, 1984
41. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
42. Fingeroth JD, Weiss JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT: Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510, 1984
43. Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm GW: Geographical prevalence of two types of Epstein-Barr virus. Virol 154:56, 1986
44. Hudson GS, Farrell PJ, Barrell BG: Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 53:528, 1985
45. Masucci MG, Ernberg I: Epstein-Barr virus: Adaption to a life within the immune system. Trends Microbiol 2:125, 1994
46. Knox PG, Li Q-X, Rickinson AB, Young LS: In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology 215:40, 1996
47. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122, 1992
48. Papadopoulos E, Ladany M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusion of donor leukocytes as treatment of Epstein-Barr virus-associated lympho-proliferative disorders complicating allogeneic marrow transformation. N Engl J Med 330:1231, 1994
49. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G: 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line Rael. J Virol 63:3135, 1989